应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02359 药明康德
已收盘 10-12 16:08:17
207.800
-0.200
-0.10%
最高
213.200
最低
206.000
成交量
320.07万
今开
213.200
昨收
208.000
日振幅
3.46%
总市值
6,265亿
流通市值
1,124亿
总股本
30.15亿
成交额
6.67亿
换手率
0.59%
流通股本
5.41亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
药明康德(02359)拟于2026年10月26日召开董事会审议前三季度业绩
公告速递 · 16:42
药明康德(02359)拟于2026年10月26日召开董事会审议前三季度业绩
券商10月金股出炉:电子、医药和银行增配居前,药明康德最热
东方财富网 · 10-09
券商10月金股出炉:电子、医药和银行增配居前,药明康德最热
生物医药板块继续回调 恒生生物科技指数跌2.31%
金吾财讯 · 10-09
生物医药板块继续回调 恒生生物科技指数跌2.31%
异动解读|药明康德盘中下跌3.16%,港股医药板块整体走弱叠加获利回吐
行情直击 · 10-09
异动解读|药明康德盘中下跌3.16%,港股医药板块整体走弱叠加获利回吐
【券商聚焦】中泰国际:多家药企将公布重要数据 推荐创新药与CXO龙头
金吾财讯 · 10-09
【券商聚焦】中泰国际:多家药企将公布重要数据 推荐创新药与CXO龙头
异动解读|药明康德盘中下跌3.11%,港股医药板块整体走弱
行情直击 · 10-08
异动解读|药明康德盘中下跌3.11%,港股医药板块整体走弱
两大板块集体调整!千亿市值龙头股价盘中创新高
中国财富 · 10-07
两大板块集体调整!千亿市值龙头股价盘中创新高
药明康德发布2026年9月股份变动月报,股本总额增至30.35亿元
公告速递 · 10-07
药明康德发布2026年9月股份变动月报,股本总额增至30.35亿元
药明康德逆势冲高,盘中股价再创历史新高
新浪港股 · 10-07
药明康德逆势冲高,盘中股价再创历史新高
药明康德创历史新高
格隆汇 · 10-07
药明康德创历史新高
异动解读|药明康德盘中上涨3.01%,机构密集增持叠加CXO板块景气上行
行情直击 · 10-06
异动解读|药明康德盘中上涨3.01%,机构密集增持叠加CXO板块景气上行
港股异动 | CRO概念股涨幅居前 小摩称不太担心利率上升影响板块 订单增长支撑后续业绩兑现
智通财经 · 10-06
港股异动 | CRO概念股涨幅居前 小摩称不太担心利率上升影响板块 订单增长支撑后续业绩兑现
港股异动 | CRO概念股涨幅居前 小摩称不太担心利率上升影响板块 订单增长支撑后续业绩兑现
智通财经 · 10-06
港股异动 | CRO概念股涨幅居前 小摩称不太担心利率上升影响板块 订单增长支撑后续业绩兑现
小摩:不太担心利率上升影响中国医疗健康行业 继续看好生物科技及CXO
智通财经 · 10-06
小摩:不太担心利率上升影响中国医疗健康行业 继续看好生物科技及CXO
快讯:恒指高开1%站上24000点 科指涨1.02% 科网股普涨 创新药概念股高开
新浪港股 · 10-06
快讯:恒指高开1%站上24000点 科指涨1.02% 科网股普涨 创新药概念股高开
生物医药板块局部活跃 金斯瑞生物科技(01548)涨4.67%、百济神州(06160)涨2.92%
金吾财讯 · 10-05
生物医药板块局部活跃 金斯瑞生物科技(01548)涨4.67%、百济神州(06160)涨2.92%
药明康德获FMR LLC增持约65.5万股 每股作价约206.86港元
新浪港股 · 10-05
药明康德获FMR LLC增持约65.5万股 每股作价约206.86港元
药明康德获扎堆推荐,机构看好节后A股反弹丨券商金股
东方财富网 · 10-03
药明康德获扎堆推荐,机构看好节后A股反弹丨券商金股
FMR LLC增持药明康德(02359)约65.5万股 每股作价约206.86港元
智通财经 · 10-02
FMR LLC增持药明康德(02359)约65.5万股 每股作价约206.86港元
异动解读|药明康德盘中下跌3.07%,报208.4港元
行情直击 · 10-02
异动解读|药明康德盘中下跌3.07%,报208.4港元
暂无数据
公司概况
公司名称:
药明康德
所属市场:
SEHK
上市日期:
--
主营业务:
无锡药明康德新药开发股份有限公司是一家主要从事新药研发和生产服务业务的中国公司。该公司主要通过六个分部开展业务。化学业务分部主要从事提供新药研究、开发与生产服务。测试业务分部主要从事提供药品、医疗器械、体外诊断试剂服务。生物学业务分部主要从事提供药物发现及研究服务。高端治疗合同测试、研发与生产(CTDMO)业务分部主要从事为客户提供医疗产品工艺开发、生产和测试一体化服务。国内新药研发服务部分部主要从事为客户提供一体化新药研发服务。其他业务分部主要从事行政服务、销售原材料和销售废料业务。
发行价格:
--
{"stockData":{"symbol":"02359","market":"HK","secType":"STK","nameCN":"药明康德","latestPrice":207.8,"timestamp":1791792497003,"preClose":208,"halted":0,"volume":3200730,"delay":0,"changeRate":-0.0009615384615384068,"floatShares":541000000,"shares":3015000000,"eps":7.748694645645813,"marketStatus":"已收盘","change":-0.2,"latestTime":"10-12 16:08:17","open":213.2,"high":213.2,"low":206,"amount":666815378,"amplitude":0.034615,"askPrice":207.8,"askSize":2000,"bidPrice":207.6,"bidSize":1900,"shortable":3,"etf":0,"ttmEps":8.638162732172427,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791855000000},"marketStatusCode":5,"adr":0,"listingDate":1544630400000,"exchange":"SEHK","adjPreClose":208,"dividendRate":0.011751,"openAndCloseTimeList":[[1791768600000,1791777600000],[1791781200000,1791792000000]],"volumeRatio":0.630593,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"WXA.HK","astockBrief":{"symbol":"603259","market":"SH","secType":"STK","nameCN":"药明康德","latestPrice":157.85,"timestamp":1791788400000,"preClose":157.8,"halted":0,"volume":29788700,"delay":0,"premium":"+12.30"},"impliedVol":0.6347,"impliedVolPercentile":0.9444},"requestUrl":"/m/hq/s/02359/tweets","defaultTab":"tweets","newsList":[{"id":"1172211402","title":"药明康德(02359)拟于2026年10月26日召开董事会审议前三季度业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=1172211402","media":"公告速递","labels":["conferences","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1172211402?lang=zh_cn&edition=full","pubTime":"2026-10-12 16:42","pubTimestamp":1791794532,"startTime":"0","endTime":"0","summary":"无锡药明康德新药开发股份有限公司(02359)12日公告称,公司董事会将于2026年10月26日(星期一)召开会议,审议并批准集团截至2026年9月30日止九个月(即2026年第三季度)的业绩及其发布事宜。届时,董事会还将处理其他相关事项。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3893e2538b44a4c9453f52433cb6ed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02359"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674685509","title":"券商10月金股出炉:电子、医药和银行增配居前,药明康德最热","url":"https://stock-news.laohu8.com/highlight/detail?id=2674685509","media":"东方财富网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674685509?lang=zh_cn&edition=full","pubTime":"2026-10-09 18:11","pubTimestamp":1791540660,"startTime":"0","endTime":"0","summary":"A股进入四季度交易时间,各大券商在10月更加青睐哪些板块和标的?整体来看,行业方面,电子是券商10月金股中权重较大的行业,且占比突出。权重增加最多的行业则是电子、医药和银行。具体到个股方面,开源证券研报数据显示,根据全市场35家券商发布的金股去重统计后,药明康德(603259)的热度最高,合计被各家券商10月金股推荐的次数最多。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"east_money_stock","url":"http://stock.eastmoney.com/news/1405,202610093891371865.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.eastmoney.com/news/1405,202610093891371865.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"east_money_stock","symbols":["LU2242644610.SGD","BK1141","LU0052750758.USD","LU1979443071.USD","LU2495084118.USD","LU1046422090.SGD","LU1303224171.USD","LU0106959298.USD","LU2125910500.SGD","LU0456842615.SGD","LU0469268626.HKD","LU1808992512.USD","LU1997245177.USD","LU0348767384.USD","161121","LU0611395673.USD","LU1719994722.HKD","LU1934453819.USD","BK0216","LU2045819591.USD","159938","BK1576","LU2328871848.SGD","BK1161","LU0708995583.HKD","LU0572944931.SGD","LU0320764599.SGD","LU1997244956.HKD","LU0327786744.USD","IE00B5MMRT66.SGD","BK1515","BK1583","LU1997245094.SGD","IE00BPRC5H50.USD","09939","IE00B543WZ88.USD","LU1770034418.SGD","LU0700851271.USD","02359","603259","BK1574","KCE","LU1969619763.USD","LU2488822045.USD","LU1251922891.USD","LU0348766576.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674188261","title":"生物医药板块继续回调 恒生生物科技指数跌2.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2674188261","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674188261?lang=zh_cn&edition=full","pubTime":"2026-10-09 10:17","pubTimestamp":1791512279,"startTime":"0","endTime":"0","summary":"金吾财讯 | 生物医药板块继续回调,恒生生物科技指数跌2.31%,恒生医疗保健指数跌2.09%。个股方面,复宏汉霖(02696)跌4.84%,药明康德(02359)跌3.92%,药明合联(02268)跌3.47%,泰格医药(03347)跌3.35%,诺诚健华(09969)跌3.27%,药明生物(02269)跌3.33%,金斯瑞生物科技(01548)跌3.10%,康诺亚-B(02162)跌2.58%,百济神州(06160)跌2.44%。","market":"other","thumbnail":"https://static.szfiu.com/news/20241108/OWU0MGRiNDM1NDA5NTM4MzU5OQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/OWU0MGRiNDM1NDA5NTM4MzU5OQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1993377","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","02696","BK1161","LU2045819591.USD","LU2778985437.USD","09969","HK0000306685.HKD","01548","IE00B0JY6N72.USD","LU1251922891.USD","02162","399441","02359","LU0359202008.SGD","LU2242644610.SGD","LU2039709279.SGD","LU0320764599.SGD","LU0516422440.USD","03347","LU0181495838.USD","LU1688375341.USD","BK4581","LU0463099449.HKD","LU0540923850.HKD","LU0128522744.USD","161726","LU0561508036.HKD","06160","LU0320764243.SGD","LU1880383366.USD","LU0327786744.USD","BK1141","02269","BK1576","LU0348825331.USD","LU0856984785.SGD","LU2125910500.SGD","SG9999014674.SGD","BK4588","LU2488822045.USD","LU0417516738.SGD","02268","BK1521","KURE","HK0000320264.USD","LU0588546209.SGD","SG9999002463.SGD","LU0417516902.SGD","LU1831875114.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152683678","title":"异动解读|药明康德盘中下跌3.16%,港股医药板块整体走弱叠加获利回吐","url":"https://stock-news.laohu8.com/highlight/detail?id=1152683678","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1152683678?lang=zh_cn&edition=full","pubTime":"2026-10-09 10:01","pubTimestamp":1791511290,"startTime":"0","endTime":"0","summary":"10月9日,药明康德盘中下跌3.16%,报202.4港元,成交额5.12亿港元。港股医药板块整体承压,药明生物跌3.33%、金斯瑞生物科技跌2.95%、药明合联跌3.16%、晶泰控股跌3.64%,CXO及创新药相关个股普遍走低,拖累药明康德表现。此前药明康德因可转债全部转股、机构密集增持及CXO板块景气度改善等利好催化,股价连续冲高并创下219.2港元历史新高,短期获利回吐压力显现。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"药明康德盘中走低,港股医药板块承压","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02359"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674892318","title":"【券商聚焦】中泰国际:多家药企将公布重要数据 推荐创新药与CXO龙头","url":"https://stock-news.laohu8.com/highlight/detail?id=2674892318","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674892318?lang=zh_cn&edition=full","pubTime":"2026-10-09 08:38","pubTimestamp":1791506310,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中泰国际表示,多家创新药企业将于10月下旬ESMO公布重要临床数据。ESMO是欧洲最具盛名和影响力的肿瘤学会议,LBA是最高级别的研究成果展示,因此ESMO公布的LBA在医药行业广受关注。中国企业入选的LBA中,有四项入选最高级别的主席研讨会。该机构认为,以上情况表明中国创新药研发能力在海外广受认可,因此创新药板块值得继续关注。","market":"other","thumbnail":"https://static.szfiu.com/news/20250109/MjdmY2Y4OTEwODUyNTc5NjI3Mg==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MjdmY2Y4OTEwODUyNTc5NjI3Mg==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1993342","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0561508036.HKD","LU0314109678.HKD","LU0348827113.USD","LU0348783233.USD","BK1191","LU0149534421.HKD","LU1831875114.USD","01093","06160","MEDX","02268","LU0307460666.USD","LU1008478684.HKD","02359","LU0067412154.USD","LU0572944931.SGD","LU2097828557.USD","LU2399975544.HKD","KCE","LU0708995153.HKD","LU1242518931.SGD","159992","BK1521","LU1960683339.HKD","IE0008369823.USD","LU2488822045.USD","IE00BZ08YR35.GBP","CXO","01801","IE00B5MMRT66.SGD","09926","LU1688375341.USD","02269","LU2125910500.SGD","00013","LU0320764599.SGD","LU0823426308.USD","LU0029874905.USD","LU0348767384.USD","01177","SG9999002463.SGD","LU2097828714.EUR","WX","LU0327786744.USD","KURE","06978","BK1500","LNGR","06821","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175969589","title":"异动解读|药明康德盘中下跌3.11%,港股医药板块整体走弱","url":"https://stock-news.laohu8.com/highlight/detail?id=1175969589","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1175969589?lang=zh_cn&edition=full","pubTime":"2026-10-08 13:39","pubTimestamp":1791437947,"startTime":"0","endTime":"0","summary":"10月8日,药明康德港股盘中下跌3.11%,报211.6港元,成交额9.35亿港元。消息面上,港股医药生物板块当日整体承压,金斯瑞生物科技跌4.1%、药明生物跌3.79%、英矽智能跌8.19%、晶泰控股跌1.92%、药明合联跌2.14%,CXO及创新药相关个股普遍走低,拖累药明康德表现。此前,药明康德因可转债全部转股、机构密集增持及CXO板块景气度改善等利好催化,股价连续冲高,短期获利回吐压力有所显现。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"药明康德盘中下跌,港股医药板块走弱","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02359"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673016894","title":"两大板块集体调整!千亿市值龙头股价盘中创新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2673016894","media":"中国财富","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673016894?lang=zh_cn&edition=full","pubTime":"2026-10-07 21:13","pubTimestamp":1791378780,"startTime":"0","endTime":"0","summary":"港股10月7日全天走低,截至收盘,恒生指数跌0.62%,报24130.5点;恒生科技指数跌0.68%,报4194.49点;恒生生物科技指数跌2.76%。半导体板块大跌2.84%,成分股中澜起科技跌6.37%,跌幅居前,ASMPT跌4.12%,兆易创新跌2.66%。恒生指数成分股层面,涨幅方面,潍柴动力大涨4.68%,领涨成分股。药明康德2026年半年度报告显示,2026年上半年,药明康德实现营业收入288.97亿元,同比增长38.94%;归母净利润110.8亿元,同比增长29.43%。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-10-07/doc-iniumivy5741115.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["MCHmain","BK1141","07552","LU0348766576.USD","LU0320764599.SGD","07300","03033","HHImain","LU0052750758.USD","513600","LU0708995583.HKD","02800","BK1576","07500","LU1046422090.SGD","LU2125910500.SGD","03417","LU0327786744.USD","LU2242644610.SGD","LU0572944931.SGD","LU2045819591.USD","BK1583","02359","03419","MHImain","HSI","03423","83115","07226","09115","03067","03115","LU0469268626.HKD","02833","03088","02837","09067","07200","HSTECH","82800","LU0348767384.USD","03032","03037","09088","603259"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104166670","title":"药明康德发布2026年9月股份变动月报,股本总额增至30.35亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1104166670","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1104166670?lang=zh_cn&edition=full","pubTime":"2026-10-07 16:36","pubTimestamp":1791362171,"startTime":"0","endTime":"0","summary":"无锡药明康德新药开发股份有限公司于2026年10月7日公告了截至2026年9月30日的股份变动月报。公告显示,公司H股数量从上月底的524,108,541股增加37,515,279股,至561,623,820股。A股数量则为2,473,280,246股,本月无新增发行或减少。公司本月底登记注册股本总额合计30.35亿元人民币。截至2026年9月23日,所有未偿还的此类可转债已全部转换为公司H股,故公司后续不再进行该债券的提前赎回事宜。截至2026年9月30日,公司已确认符合适用的香港联交所最低公众持股量要求。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02359"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673109670","title":"药明康德逆势冲高,盘中股价再创历史新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2673109670","media":"新浪港股","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673109670?lang=zh_cn&edition=full","pubTime":"2026-10-07 16:22","pubTimestamp":1791361320,"startTime":"0","endTime":"0","summary":"热点栏目自选股\n数据中心\n行情中心\n资金流向\n模拟交易客户端10月7日消息,药明康德(02359.HK)港股午后一度触及219.2港元/股,创历史新高,总市值达6652.51亿港元。当日港股大盘整体承压,恒指收跌0.62%,医药生物板块多数走低。今年上半年,药明康德实现营业收入288.97亿元,同比增长38.94%;归母净利润110.8亿元,同比增长29.43%。申万宏源研报指出,多肽、寡核苷酸等新分子需求增长,GLP-1放量带动TIDES业务扩张,以及工艺积累与产能布局强化竞争优势,有望支撑公司中长期业绩增长。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/2026-10-07/doc-iniukxhi4641280.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1046422090.SGD","LU0708995583.HKD","IE00B5MMRT66.SGD","LU1934453819.USD","LU0327786744.USD","BK0216","LU1251922891.USD","LU1719994722.HKD","LU1969619763.USD","BK1583","LU1808992512.USD","LU2488822045.USD","LU0348767384.USD","IE00BPRC5H50.USD","BK1576","LU0456842615.SGD","LU2328871848.SGD","LU1979443071.USD","LU0052750758.USD","02359","LU0106959298.USD","LU1303224171.USD","LU0572944931.SGD","IE00B543WZ88.USD","LU1997244956.HKD","LU1997245177.USD","LU2242644610.SGD","LU0320764599.SGD","LU0348766576.USD","BK1141","LU0469268626.HKD","LU2125910500.SGD","LU0700851271.USD","LU2045819591.USD","LU1997245094.SGD","LU2495084118.USD","603259","LU1770034418.SGD","LU0611395673.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673865093","title":"药明康德创历史新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2673865093","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673865093?lang=zh_cn&edition=full","pubTime":"2026-10-07 14:14","pubTimestamp":1791353642,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0348766576.USD","BK1583","LU0469268626.HKD","BK1141","LU0327786744.USD","LU2045819591.USD","LU0708995583.HKD","02359","LU0348767384.USD","LU2125910500.SGD","LU2242644610.SGD","BK1576","LU0320764599.SGD","LU0572944931.SGD","LU0052750758.USD","LU1046422090.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195876204","title":"异动解读|药明康德盘中上涨3.01%,机构密集增持叠加CXO板块景气上行","url":"https://stock-news.laohu8.com/highlight/detail?id=1195876204","media":"行情直击","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1195876204?lang=zh_cn&edition=full","pubTime":"2026-10-06 13:52","pubTimestamp":1791265977,"startTime":"0","endTime":"0","summary":"10月6日,药明康德盘中上涨3.01%,报218.8港元,成交额3.71亿港元。机构连续增持释放积极信号,叠加CXO板块整体景气度改善,共同助推股价走强。药明康德所在的CXO板块近期表现活跃,中邮证券研报指出,2026中报显示CXO行业是医药行业中最亮眼板块之一,CDMO龙头、安评及临床CRO构成三条景气主线。中信建投亦表示,随着内外需改善逐步传导至订单与业绩,CXO有望进入新一轮增长阶段。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"机构密集增持药明康德,CXO景气上行","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02359"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673187035","title":"港股异动 | CRO概念股涨幅居前 小摩称不太担心利率上升影响板块 订单增长支撑后续业绩兑现","url":"https://stock-news.laohu8.com/highlight/detail?id=2673187035","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673187035?lang=zh_cn&edition=full","pubTime":"2026-10-06 11:55","pubTimestamp":1791258904,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2045819591.USD","LU1242518857.USD","LU0359201612.USD","LU2125910500.SGD","LU0417516902.SGD","KURE","03347","LU1688375341.USD","LU0417516738.SGD","LU2778985437.USD","IE00B0JY6N72.USD","LU0128522744.USD","LU0327786744.USD","LU0456846285.SGD","SG9999002463.SGD","LU0211977185.USD","LU0516422952.EUR","LU0572944931.SGD","BK1583","LU0043850808.USD","LU0588546209.SGD","LU0516423174.USD","LU0181495838.USD","BK1610","SG9999002562.SGD","BK1141","02359","LU3063872942.SGD","LU0039217434.USD","LU0823426308.USD","LU0540923850.HKD","LU0348767384.USD","LU1046422090.SGD","LU0348825331.USD","LU0708995583.HKD","LU0456827905.SGD","LU2476274720.SGD","LU0469268626.HKD","LU1880383366.USD","LU0140636845.USD","BK1576","BK1589","LU0708995153.HKD","03759","LU1720050803.USD","LU0856984785.SGD","02269","LU1242518931.SGD","LU0348735423.USD","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673003518","title":"港股异动 | CRO概念股涨幅居前 小摩称不太担心利率上升影响板块 订单增长支撑后续业绩兑现","url":"https://stock-news.laohu8.com/highlight/detail?id=2673003518","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673003518?lang=zh_cn&edition=full","pubTime":"2026-10-06 11:55","pubTimestamp":1791258904,"startTime":"0","endTime":"0","summary":"摩根大通发布研报称,不太担心利率上升影响中国医疗健康行业。该行预期本轮加息周期将于12月再加息一次后结束,而非延续至明年的长期紧缩,因此对利率上升影响中国医疗健康估值并不太担心,并继续看好生物科技及CXO子板块。国盛证券指出,订单增长叠加ADC、GLP-1、核酸药物等新兴领域产能进入收获期,为后续CXO收入增长提供支撑,订单转化及利润兑现值得持续跟踪。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1503855.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02359","LU2023250504.SGD","TFNS","PEX","LU3063872942.SGD","03759","IE00BN8TJ469.HKD","LU0256863902.USD","LU1261432733.SGD","JPO","IYF","BK4516","LU0211328371.USD","XLF","IE00BBT3K403.USD","LU2236285917.USD","FNCL","LU2552382215.SGD","EQRR","LU1162221912.USD","BK1583","LU0039217434.USD","LU0140636845.USD","LU1064131342.USD","KBWB","LU0882574139.USD","LU0128526141.USD","LU0348735423.USD","IXG","FTXO","LU2417539215.USD","VFH","LU2045819591.USD","LU0211331839.USD","XLBI","KURE","KCAI","LU1974910355.USD","LU0029874061.USD","LU2023250843.SGD","JPMO","TRUF","02269","LU0267386448.USD","UYG","VXUS","LU1688375341.USD","IYG","03347","LU1551013425.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673035134","title":"小摩:不太担心利率上升影响中国医疗健康行业 继续看好生物科技及CXO","url":"https://stock-news.laohu8.com/highlight/detail?id=2673035134","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673035134?lang=zh_cn&edition=full","pubTime":"2026-10-06 11:32","pubTimestamp":1791257520,"startTime":"0","endTime":"0","summary":"另外,该行预期本轮加息周期将于12月再加息一次后结束,而非延续至明年的长期紧缩,因此对利率上升影响中国医疗健康估值并不太担心,并继续看好生物科技及CXO子板块。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1503851.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02268","KURE","06990","LU1974910355.USD","LABU","XLBI","CXO","IEIH","XBI","159760","EQRR","IE0034235295.USD","JPO","LU1670627923.USD","XLV","IBBJ","MEDX","VHT","IXG","GDOC","FNCL","03696","LNGR","159837","TRUF","LU0708995153.HKD","KBWB","02269","IYF","TFNS","VFH","JPMO","LU2168564065.EUR","UYG","XLF","01548","PEX","SYNB","LU0345769631.USD","02359","LU0345769128.USD","FTXO","IE00BKDWB100.SGD","HBImain","IYG","LU0976567544.SGD","LU0572944931.SGD","WX","IXJ","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673386490","title":"快讯:恒指高开1%站上24000点 科指涨1.02% 科网股普涨 创新药概念股高开","url":"https://stock-news.laohu8.com/highlight/detail?id=2673386490","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673386490?lang=zh_cn&edition=full","pubTime":"2026-10-06 09:20","pubTimestamp":1791249600,"startTime":"0","endTime":"0","summary":"热点栏目自选股\n数据中心\n行情中心\n资金流向\n模拟交易客户端美股周一走势反复向好,虽然美国国债收益率持续上升,拖累大市早段一度承压,但其后在科技股发力带动下全面回升,美股三大指数均录得升幅收市,其中纳斯达克指数再创历史新高。美元高位靠稳,美国十年期债息则攀升至5.3厘水平,金价反复偏软,油价走势亦有所回落。今日港股三大指数集体高开,恒指开盘涨1%,报24279.63点,恒科指涨1.02%,国企指数涨0.99%。盘面上,科网股普涨,阿里巴巴涨超2%,百度、美团、哔哩哔哩涨超1%;电力设备股高开,潍柴动力涨超1%;创新药概念股普涨,药明康德涨超1%;有色金属板块活跃,中国铝业涨超1%。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-10-06/doc-iniufxci2072171.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["03086","LU0348766576.USD","LU2242644610.SGD","603259","MCHmain","LU1880383366.USD","LU0128525689.USD","LU1242518931.SGD","LU0072462343.USD","BK1576","QQQA","IYW","09988","LU0797268264.HKD","LU0052756011.USD","BK4524","LU1152091754.HKD","BK4531","LU1003077747.HKD","BK4505","QID","BK4533","MNQmain","LU1769817096.USD","BK4504","LU0067412154.USD","LU0949170772.SGD","LU1769817179.HKD","LU0348767384.USD","BK4565","SQQQ","LU1235294995.USD","07200","LU0545039389.USD","LU1515016050.SGD","LU1242518857.USD","BK1141","LU0821914370.USD","BABW","NQmain","BABX","PSQ","83115","BK4558","LU0738911758.USD","LU1282648689.USD","BK4527","BABU","LU1048588211.SGD","NVIW.SI","LU0501845795.SGD","LU0348814723.USD","BK4220","LU1048596156.SGD","BK4538","LU0708995583.HKD","LU0251143458.SGD","QQQE","BK4575","ONLN","LU2045819591.USD","QQQJ","JEPQ","LU1046421795.USD","LU0052750758.USD",".IXIC","03419","LU2148611432.USD","ONEQ","LU1823568750.SGD","LU0918141705.HKD","LU0661504455.SGD","LU0979878070.USD","BK4579","LU0572944931.SGD","QLD","BK4502","BBYY","QQQM","BABA","LU0310800965.SGD","82800","BK4554","02833","07500","03115","BABC","BK4607","LU1267930227.SGD","LU2125910500.SGD","LU0328353924.USD","LU0469268626.HKD","03037","09115","02359","BK4614","IE00B0JY6N72.USD","LU0880133367.SGD","BK4587","07300","BK4503","IE00BF5LJ272.USD","TQQQ","LU0651947912.USD","NDX","LU0651946864.USD","LU1152091168.USD","LU0320764599.SGD","BK1583","LU0553294199.USD","LU1051769294.HKD","QQQY","IE00BFMHRM44.USD","LU1046422090.SGD","LU1105468828.SGD","QYLG","BK4585","CLIX","FTEC","ALBmain","LU0106959298.USD","TQQY","LU0918141887.USD","LU0327786744.USD","BK4543","513600","DRAG","BK4526","LU1051768304.USD","QQQ","LU0072913022.USD","02800","LU0456842615.SGD","HHImain","BK4535","BK4548","HSTECH","BK4588","GPIQ","LU1008478684.HKD","KBAB",".HXC","LU0348816934.USD","BK4122","LU2226246903.HKD","BK4534","BABO","HSI","QDTE","TECS","LU1688375341.USD","BK4581","LU0047713382.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673770524","title":"生物医药板块局部活跃 金斯瑞生物科技(01548)涨4.67%、百济神州(06160)涨2.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2673770524","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673770524?lang=zh_cn&edition=full","pubTime":"2026-10-05 14:10","pubTimestamp":1791180649,"startTime":"0","endTime":"0","summary":"金吾财讯 | 生物医药板块局部表现活跃,截至发稿,金斯瑞生物科技 涨4.67%,百济神州涨2.92%,药明生物涨1.65%,药明康德涨1.14%。消息面上,山西证券表示,AI模型公司以及众多MNC对AI高度重视已充分说明AI制药是未来AI应用的重要方向之一。短期看,通过AI模型设计的大量药物分子有望转化成上游服务企业的新增订单;中长期看,AI制药未来有望大幅提高药物研发效率和研发质量。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250110/MDc3ODQ0ZjRmZjY3NDY3NWE2ZmExZWEzMjkyYmRjMmI4NjI3MTMyNDA2NzU1.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/MDc3ODQ0ZjRmZjY3NDY3NWE2ZmExZWEzMjkyYmRjMmI4NjI3MTMyNDA2NzU1.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1993064","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0029874905.USD","161726","LU0516422440.USD","LU0516422366.SGD","LU2125910500.SGD","IE00B0JY6N72.USD","LU0417516902.SGD","ONC","LU1242518857.USD","BK4585","06160","LU0348767384.USD","LU2476274720.SGD","XBI","LU0051755006.USD","LU0540923850.HKD","BK4581","LU0039217434.USD","LU2045819591.USD","01548","LU0828237510.HKD","LU2778985437.USD","LU0708995583.HKD","688235","HK0000306701.USD","LU0320764599.SGD","LU0572944931.SGD","LU0634319403.HKD","BK1610","LU0327786744.USD","399441","02269","HK0000306685.HKD","LU0128526141.USD","LU0320764243.SGD","LU0456827905.SGD","LU0561508036.HKD","LU2039709279.SGD","LU0211977185.USD","LU0181495838.USD","KURE","LU1770034418.SGD","02359","LU0228659784.USD","LU0307460666.USD","BK4526","LU0819121731.USD","LU0348766576.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673779802","title":"药明康德获FMR LLC增持约65.5万股 每股作价约206.86港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2673779802","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673779802?lang=zh_cn&edition=full","pubTime":"2026-10-05 07:58","pubTimestamp":1791158280,"startTime":"0","endTime":"0","summary":"热点栏目自选股\n数据中心\n行情中心\n资金流向\n模拟交易客户端香港联交所最新数据显示,9月28日,FMR LLC增持药明康德(02359)65.4971万股,每股作价206.8641港元,总金额约为1.35亿港元。增持后最新持股数目约为5646.61万股,持股比例为10.05%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-10-05/doc-iniucpwp9792215.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0572944931.SGD","603259","LU0611395673.USD","LU0700851271.USD","LU0348767384.USD","IE00BPRC5H50.USD","LU2495084118.USD","BK1576","LU1251922891.USD","LU1303224171.USD","02359","LU1719994722.HKD","LU0052750758.USD","LU0456842615.SGD","LU1934453819.USD","LU1997245177.USD","LU1997245094.SGD","LU0708995583.HKD","BK1583","IE00B5MMRT66.SGD","LU2488822045.USD","LU2045819591.USD","LU2328871848.SGD","LU1979443071.USD","LU1997244956.HKD","LU0320764599.SGD","LU0469268626.HKD","EWH","LU2242644610.SGD","IE00B543WZ88.USD","LU1969619763.USD","LU0327786744.USD","BK1141","LU0348766576.USD","LU1046422090.SGD","LU2125910500.SGD","BK0216","LU1808992512.USD","LU1770034418.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672742345","title":"药明康德获扎堆推荐,机构看好节后A股反弹丨券商金股","url":"https://stock-news.laohu8.com/highlight/detail?id=2672742345","media":"东方财富网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2672742345?lang=zh_cn&edition=full","pubTime":"2026-10-03 08:01","pubTimestamp":1790985673,"startTime":"0","endTime":"0","summary":"9月最后一个交易日,A股三大指数涨跌不一,截至收盘,上证指数涨0.31%,深证成指跌0.11%,创业板指跌0.23%;北证50涨0.7%。沪深两市成交额约14380.18亿元,较前一个交易日放量约288.21亿元。全市场2567只股票上涨、2824只股票下跌,其中56只涨停、12只跌停。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"east_money_stock","url":"http://stock.eastmoney.com/news/1405,202610033888455177.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.eastmoney.com/news/1405,202610033888455177.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"east_money_stock","symbols":["LU0456842615.SGD","02843","02823","07233","83130","LU0708995583.HKD","82846","BK1610","LU0611395673.USD","KCE","LU0348767384.USD","02822","IE00B543WZ88.USD","IE00B5MMRT66.SGD","03130","LU1997245177.USD","LU1934453819.USD","83188","BK0216","LU2495084118.USD","399300","159982","LU1979443071.USD","LU2045819591.USD","LU1303224171.USD","LU2242644610.SGD","82843","LU2328871848.SGD","BK1141","82823","LU1808992512.USD","03188","LU0320764599.SGD","LU2488822045.USD","IE00BPRC5H50.USD","LU0327786744.USD","LU1969619763.USD","LU1251922891.USD","LU1770034418.SGD","BK1576","603259","BK1583","02827","LU1719994722.HKD","02359","LU0348766576.USD","02846","LU2125910500.SGD","82822","LU0572944931.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672712104","title":"FMR LLC增持药明康德(02359)约65.5万股 每股作价约206.86港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2672712104","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2672712104?lang=zh_cn&edition=full","pubTime":"2026-10-02 20:54","pubTimestamp":1790945677,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,香港联交所最新数据显示,9月28日,FMR LLC增持药明康德(02359)65.4971万股,每股作价206.8641港元,总金额约为1.35亿港元。增持后最新持股数目约为5646.61万股,持股比例为10.05%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1503438.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BPRC5H50.USD","LU0348767384.USD","LU0708995583.HKD","LU1808992512.USD","EWH","LU0320764599.SGD","LU1979443071.USD","LU2242644610.SGD","LU2125910500.SGD","LU2328871848.SGD","LU0348766576.USD","BK1583","LU0327786744.USD","IE00B5MMRT66.SGD","LU1719994722.HKD","603259","LU1046422090.SGD","LU1303224171.USD","LU0469268626.HKD","LU0052750758.USD","LU2488822045.USD","LU2045819591.USD","LU0456842615.SGD","BK1141","LU0611395673.USD","02359","LU1997245094.SGD","LU1997245177.USD","IE00B543WZ88.USD","LU1969619763.USD","BK1576","LU2495084118.USD","LU1251922891.USD","LU0700851271.USD","LU1997244956.HKD","LU0572944931.SGD","BK0216","LU1934453819.USD","LU1770034418.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102234736","title":"异动解读|药明康德盘中下跌3.07%,报208.4港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1102234736","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1102234736?lang=zh_cn&edition=full","pubTime":"2026-10-02 09:37","pubTimestamp":1790905065,"startTime":"0","endTime":"0","summary":"10月2日,药明康德盘中下跌3.07%,报208.4港元/股,成交额1.75亿港元。药明康德所在的生命科学工具和服务行业中,板块个股普遍走低,其中药明生物跌3.48%,金斯瑞生物科技跌3.03%,英矽智能跌5.99%,药明合联跌4.51%,晶泰控股跌5.68%。公司是全球医药及生命科学行业一体化、端到端新药研发和生产服务提供商,业务涵盖化学药研发和生产、生物学研究、临床前测试和临床研发等领域,通过CRDMO模式服务全球客户。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02359"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.wuxiapptec.com.cn","stockEarnings":[{"period":"1week","weight":-0.0095},{"period":"1month","weight":0.0766},{"period":"3month","weight":0.345},{"period":"6month","weight":0.6296},{"period":"1year","weight":0.7701},{"period":"ytd","weight":1.1414}],"compareEarnings":[{"period":"1week","weight":0.01},{"period":"1month","weight":-0.0421},{"period":"3month","weight":0.0015},{"period":"6month","weight":-0.065},{"period":"1year","weight":-0.095},{"period":"ytd","weight":-0.0554}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"无锡药明康德新药开发股份有限公司是一家主要从事新药研发和生产服务业务的中国公司。该公司主要通过六个分部开展业务。化学业务分部主要从事提供新药研究、开发与生产服务。测试业务分部主要从事提供药品、医疗器械、体外诊断试剂服务。生物学业务分部主要从事提供药物发现及研究服务。高端治疗合同测试、研发与生产(CTDMO)业务分部主要从事为客户提供医疗产品工艺开发、生产和测试一体化服务。国内新药研发服务部分部主要从事为客户提供一体化新药研发服务。其他业务分部主要从事行政服务、销售原材料和销售废料业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.026729},{"month":2,"riseRate":0.5,"avgChangeRate":0.002973},{"month":3,"riseRate":0.375,"avgChangeRate":-0.010735},{"month":4,"riseRate":0.5,"avgChangeRate":0.006501},{"month":5,"riseRate":0.375,"avgChangeRate":-0.004537},{"month":6,"riseRate":0.75,"avgChangeRate":0.089541},{"month":7,"riseRate":0.75,"avgChangeRate":0.092416},{"month":8,"riseRate":0.625,"avgChangeRate":0.059692},{"month":9,"riseRate":0.625,"avgChangeRate":0.094161},{"month":10,"riseRate":0.375,"avgChangeRate":-0.006225},{"month":11,"riseRate":0.285714,"avgChangeRate":-0.00294},{"month":12,"riseRate":0.571429,"avgChangeRate":0.03824}],"exchange":"SEHK","name":"药明康德","nameEN":"WUXI APPTEC"},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"药明康德(02359)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供药明康德(02359)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"药明康德,02359,药明康德股票,药明康德股票老虎,药明康德股票老虎国际,药明康德行情,药明康德股票行情,药明康德股价,药明康德股市,药明康德股票价格,药明康德股票交易,药明康德股票购买,药明康德股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"药明康德(02359)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供药明康德(02359)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}